Placebo
SPR720-202
Phase 2 small_molecule completed
Quick answer
Placebo for Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD) is a Phase 2 program (small_molecule) at Spero Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Spero Therapeutics
- Indication
- Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed